Editorial Board for section 'Plasma Cell Disorders'
- Chronic Myeloid Disease Section
- Coagulation Section
- Leukemias Section
- Lymphomas Section
- Plasma Cell Disorders Section
- Radiolabeled Blood Elements and Other Imaging Modalities Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Service d'Hématologie, Hôpital Pitié Salpêtrière, 47‐83 boulevard de l'hôpital, F‐75013 Paris, France
Interests: myeloma; AL amyloidosis; monoclonal gammopathy of clinical significance; POEMS; transplantation
Special Issues, Collections and Topics in MDPI journals
Interests: myeloma; AL amyloidosis; monoclonal gammopathy of clinical significance; POEMS; transplantation
Special Issues, Collections and Topics in MDPI journals
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain
Interests: monoclonal gammopathies; multiple myeloma; amyloidosis
Interests: monoclonal gammopathies; multiple myeloma; amyloidosis
Section of Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK
Interests: multiple myeloma; clinical trial design and delivery; tumour immunology & immunotherapy
Interests: multiple myeloma; clinical trial design and delivery; tumour immunology & immunotherapy
IUC-Oncopole, Centre de Recherche en Cancérologie de Toulouse INSERMU1037, Toulouse, France
Interests: multiple myeloma; genomic; prognosis; minimal residual disease; microenvironment
Interests: multiple myeloma; genomic; prognosis; minimal residual disease; microenvironment
Department of Hematology, University Hospital Leuven, Leuven, Belgium
Interests: multiple myeloma; new drugs; adverse events; quality of life; drug resistance; AL amyloidosis
Special Issues, Collections and Topics in MDPI journals
Interests: multiple myeloma; new drugs; adverse events; quality of life; drug resistance; AL amyloidosis
Special Issues, Collections and Topics in MDPI journals
1st Department of Internal Medicine, Division of Hematology, Aristotle University Medical School, AXEPA University Hospital of Thessaloniki, St Kyriakides 1 Street, Thessaloniki, Greece
Interests: waldenstrom macroglobulinemia; multiple myeloma; AL amyloidosis; MGUS; plasma cell leukemia; lymphomas; monoclonal and bispecific antibodies; clinical trials in plasma cell dyscrasias; precision med
Interests: waldenstrom macroglobulinemia; multiple myeloma; AL amyloidosis; MGUS; plasma cell leukemia; lymphomas; monoclonal and bispecific antibodies; clinical trials in plasma cell dyscrasias; precision med
Department of Stem Cell Transplantation, UKE, 20246 Hamburg, Germany
Interests: stem cell biology in myelofibrosis; allogeneic stem cell transplantation from unrelated donors; prevention and treatment of the donor-to-host response; cellular immunotherapy with genetically modified stem cells and T cells (CAR T cells); detection of minimal residual disease; molecular genetics in myeloid diseases; multiple myeloma; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Interests: stem cell biology in myelofibrosis; allogeneic stem cell transplantation from unrelated donors; prevention and treatment of the donor-to-host response; cellular immunotherapy with genetically modified stem cells and T cells (CAR T cells); detection of minimal residual disease; molecular genetics in myeloid diseases; multiple myeloma; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19, 27100 Pavia, Italy
Interests: amyloidosis; monoclonal gammopathies of clinical significance; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: amyloidosis; monoclonal gammopathies of clinical significance; biomarkers
Special Issues, Collections and Topics in MDPI journals
Sorbonne Université, INSERM U938, Centre de Recherche Saint-Antoine, F-75012 Paris, France
Interests: cancer; myeloma; mesenchymal stem cells; signaling pathways; differenciation
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; myeloma; mesenchymal stem cells; signaling pathways; differenciation
Special Issues, Collections and Topics in MDPI journals
1. Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway
2. KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Interests: clinical studies in myeloma; PET-CT; MRD-driven trials
Special Issues, Collections and Topics in MDPI journals
2. KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway
Interests: clinical studies in myeloma; PET-CT; MRD-driven trials
Special Issues, Collections and Topics in MDPI journals
Department of Clinical Therapeutics, School of Medicine, University of Athens, Athens, Greece
Interests: multiple myeloma; bone marrow; hematological malignancies; hematologic diseases; fracture; osteoporosis; bone biology; bone metabolism; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Interests: multiple myeloma; bone marrow; hematological malignancies; hematologic diseases; fracture; osteoporosis; bone biology; bone metabolism; myelodysplastic syndromes
Special Issues, Collections and Topics in MDPI journals
Cancer Center Amsterdam, Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands
Interests: multiple myeloma; immunotherapy; CD38-targeting antibodies; bispecific antibodies; plasma cell leukemia; MGUS
Interests: multiple myeloma; immunotherapy; CD38-targeting antibodies; bispecific antibodies; plasma cell leukemia; MGUS
Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
Interests: imaging in multiple myeloma; minimal residual disease; treatment of transplant eligible patients; phase III protocols
Interests: imaging in multiple myeloma; minimal residual disease; treatment of transplant eligible patients; phase III protocols
